ADCC-Enhanced anti-Activin B (ActRIIa-mFc) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased binding affinity for the FcyR receptor on immune effector cells. ADCC-Enhanced anti-Activin B biobetter https://adcc.creative-biolabs.com/adcc-enhanced-anti-activin-b-biobetter-1031.htm